Emmaus Life Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

CONVERTIBLE DEBT AND EQUITY FINANCINGS (Tables)

12 Months Ended

Sep. 30, 2014

		As of September 30, 2014
						Carrying
		Balance		Discount		Value
Note Type and Investor	Due Date	($)		($)		($)
Senior Secured 5% Notes Convertible at $0.25
(the “September 2014 Notes”)

RSJ Private Equity	03/21/2016	$	750,000	$	(67,900)	$	682,100
4 Accredited Investors	03/21/2016		300,000		(28,900)		271,100
John Pappajohn	03/21/2016		200,000		(25,800)		174,200
Tierney Family Trust	03/21/2016		200,000		(25,800)		174,200
Oman Ventures	03/21/2016		200,000		(25,800)		174,200
Total Secured Convertible Promissory (September 2014) Notes		$	1,650,000	$	(174,200)	$	1,475,800